PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 70,000 Value ($000) $2,702 Avg Close $43.60 Range $33.31 - $48.89

Q4 2023

Shares 319,000 Value ($000) $7,315 Avg Close $17.50 Range $13.72 - $23.88

Q2 2023

Shares 35,000 Value ($000) $967 Avg Close $25.03 Range $17.64 - $30.10

Q1 2020

Shares 158,222 Value ($000) $1,117 Avg Close $7.49 Range $5.30 - $9.30

Q4 2019

Shares 78,326 Value ($000) $552 Avg Close $9.93 Range $4.47 - $13.77

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	70,000	$2,702	$43.60	$33.31 - $48.89
Q4 2023	319,000	$7,315	$17.50	$13.72 - $23.88
Q2 2023	35,000	$967	$25.03	$17.64 - $30.10
Q1 2020	158,222	$1,117	$7.49	$5.30 - $9.30
Q4 2019	78,326	$552	$9.93	$4.47 - $13.77